Host genetic factors and antiviral immune responses to hepatitis C virus - PubMed (original) (raw)

Review

Host genetic factors and antiviral immune responses to hepatitis C virus

Chloe L Thio. Clin Liver Dis. 2008 Aug.

Abstract

Human genome variations explain some of the heterogeneity in the immune response to antigenic stimuli. Such differences in response to hepatitis C virus (HCV) antigens can account for the ability of the immune response to clear HCV after an acute infection or to develop more rapidly progressive liver disease. Several studies have examined polymorphisms in several candidate immune-response genes for their relation to these HCV outcomes. Results of some of these studies complement knowledge gained from immunology studies, and others offer new insights into HCV biology. This review summarizes published studies on variation in immune-response genes and HCV outcomes.

PubMed Disclaimer

Similar articles

• Host background factors contributing to hepatitis C virus clearance.
  Isaguliants MG, Ozeretskovskaya NN. Isaguliants MG, et al. Curr Pharm Biotechnol. 2003 Jun;4(3):185-93. doi: 10.2174/1389201033489838. Curr Pharm Biotechnol. 2003. PMID: 12769762 Review.
• Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.
  Rosenberg BR, Depla M, Freije CA, Gaucher D, Mazouz S, Boisvert M, Bédard N, Bruneau J, Rice CM, Shoukry NH. Rosenberg BR, et al. PLoS Pathog. 2018 Sep 17;14(9):e1007290. doi: 10.1371/journal.ppat.1007290. eCollection 2018 Sep. PLoS Pathog. 2018. PMID: 30222771 Free PMC article.
• Innate immune responses to hepatitis C virus.
  Schoggins JW, Rice CM. Schoggins JW, et al. Curr Top Microbiol Immunol. 2013;369:219-42. doi: 10.1007/978-3-642-27340-7_9. Curr Top Microbiol Immunol. 2013. PMID: 23463203 Review.
• [Hepatitis C virus (Flaviviridae: Hepacivirus: Hepacivirus C): regulation of signaling reactions of innate immunity].
  Sokolova TM. Sokolova TM. Vopr Virusol. 2021 Jan 7;65(6):307-316. doi: 10.36233/0507-4088-2020-65-6-1. Vopr Virusol. 2021. PMID: 33533227 Review. Russian.
• Immune control and failure in HCV infection--tipping the balance.
  Dustin LB, Cashman SB, Laidlaw SM. Dustin LB, et al. J Leukoc Biol. 2014 Oct;96(4):535-48. doi: 10.1189/jlb.4RI0214-126R. Epub 2014 Jul 11. J Leukoc Biol. 2014. PMID: 25015956 Free PMC article. Review.

Cited by

• Zika Virus Infects Human Placental Macrophages.
  Quicke KM, Bowen JR, Johnson EL, McDonald CE, Ma H, O'Neal JT, Rajakumar A, Wrammert J, Rimawi BH, Pulendran B, Schinazi RF, Chakraborty R, Suthar MS. Quicke KM, et al. Cell Host Microbe. 2016 Jul 13;20(1):83-90. doi: 10.1016/j.chom.2016.05.015. Epub 2016 May 27. Cell Host Microbe. 2016. PMID: 27247001 Free PMC article.
• Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4.
  Hemeda AA, Ahmad Mohamed A, Aziz RK, Abdel-Hakeem MS, Ali-Tammam M. Hemeda AA, et al. Viruses. 2021 Apr 20;13(4):714. doi: 10.3390/v13040714. Viruses. 2021. PMID: 33924242 Free PMC article.
• A multifaceted computational report on the variants effect on KIR2DL3 and IFNL3 candidate gene in HCV clearance.
  Singh P, Dass JF. Singh P, et al. Mol Biol Rep. 2016 Oct;43(10):1101-17. doi: 10.1007/s11033-016-4044-5. Epub 2016 Jul 26. Mol Biol Rep. 2016. PMID: 27461217
• The reduced predictive value of interleukin 28b gene polymorphisms in a cohort of patients with thyroiditis developed during antiviral therapy for chronic hepatitis C: a preliminary study.
  Tran HA, Jones TL, Ianna EA, Gibson RA, Reeves GE. Tran HA, et al. Hepat Mon. 2012 Aug;12(8):e6036. doi: 10.5812/hepatmon.6036. Epub 2012 Aug 30. Hepat Mon. 2012. PMID: 23087747 Free PMC article.
• Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.
  Puri CP. Puri CP. J Clin Exp Hepatol. 2011 Jun;1(1):27-33. doi: 10.1016/S0973-6883(11)60115-1. Epub 2011 Aug 26. J Clin Exp Hepatol. 2011. PMID: 25755307 Free PMC article.

References

1. 1. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999;29:908–914. - PubMed
2. 1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825–832. - PubMed
3. 1. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr. 1993;6:602–610. - PubMed
4. 1. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450–456. - PubMed
5. 1. Kenny-Walsh E Irish Hepatology Research Group. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med. 1999;340:1228–1233. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central
  • W.B. Saunders

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information